Sort   by:  
 Page size 
UnknownA randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN study.
Not available
S-EPMC5222915 | biostudies-literature
UnknownPalbociclib in Combination with either Aromatase Inhibitors or Fulvestrant for Patients with Advanced HR+/HER2- Breast Cancer in Germany: Final Results of the Phase 2 Multicohort INGE-B Trial.
Not available
S-EPMC11809519 | biostudies-literature
UnknownIndirect Treatment Comparison between Ribociclib Combined with Non-Steroidal Aromatase Inhibitors and Ovarian Function Suppression vs. Tamoxifen in Premenopausal Women with Early Breast Cancer.
Not available
S-EPMC12158542 | biostudies-literature
UnknownSubcutaneous injection of trastuzumab into the thigh versus abdominal wall in patients with HER2-positive early breast cancer: Pharmacokinetic, safety and patients' preference - Substudy of the randomised phase III GAIN-2 study.
Not available
S-EPMC9563210 | biostudies-literature
UnknownAGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2020.
Not available
S-EPMC7383289 | biostudies-literature
UnknownAGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2019.
Not available
S-EPMC6751428 | biostudies-literature
UnknownAGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2019.
Not available
S-EPMC6751475 | biostudies-literature
Sort   by:  
 Page size